Drug Eluting Balloons (DEB) Market Research:GAGR is expected to be 12.8% in the next few years

A drug-eluting balloon is a non-stent technology in which the effective homogenous delivery of anti-proliferative drugs is processed by the vessel wall through an inflated balloon. This is done to restore luminal vascularity in order to treat atherosclerosis, in-stent restenosis and reduce the risk of late thrombosis without implanting a permanent foreign object. The balloon technology relies on the concept of targeted drug delivery, which helps in the rapid healing of the vessel wall and prevents the proliferation of smooth muscle cells.

Drug eluting balloon is a semi-compliant angioplasty balloon, coated with anti-proliferative medicine. The medicine is ejected to the vessel walls during the inflation of the balloon. The balloons are inflated through application of nominal pressure.

Source: Secondary Literature and QYResearch, 2021

According to the new market research report “Drug Eluting Balloons (DEB) - Global Market Insights and Sales Trends 2024”, published by QYResearch, the global Drug Eluting Balloons（DEB） market size is projected to reach USD 1.56 billion by 2029, at a CAGR of 12.8% during the forecast period.

• Global Drug Eluting Balloons（DEB） Market Size(US$ Million), 2018-2029

Source: QYResearch, “Drug Eluting Balloons (DEB) - Global Market Insights and Sales Trends 2024”

• Global Drug Eluting Balloons（DEB） Top3 Players Rankingand Market Share（Based on data of 2021, Continually updated）

Source: QYResearch, “Drug Eluting Balloons (DEB) - Global Market Insights and Sales Trends 2024”

The global key manufacturers of Drug Eluting Balloons（DEB） include B. Braun, Medtronic, etc. In 2021, the global top three players had a share approximately 69.0% in terms of revenue.

About QYResearch

QYResearch founded in California, USA in 2007.It is a leading global market research and consulting company. With over 16 years’ experience and professional research team in various cities over the world QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability. Up to now, we have cooperated with more than 60,000 clients across five continents. Let’s work closely with you and build a bold and better future.

QYResearch is a world-renowned large-scale consulting company. The industry covers various high-tech industry chain market segments, spanning the semiconductor industry chain (semiconductor equipment and parts, semiconductor materials, ICs, Foundry, packaging and testing, discrete devices, sensors, optoelectronic devices), photovoltaic industry chain (equipment, cells, modules, auxiliary material brackets, inverters, power station terminals), new energy automobile industry chain (batteries and materials, auto parts, batteries, motors, electronic control, automotive semiconductors, etc.), communication industry chain (communication system equipment, terminal equipment, electronic components, RF front-end, optical modules, 4G/5G/6G, broadband, IoT, digital economy, AI), advanced materials industry Chain (metal materials, polymer materials, ceramic materials, nano materials, etc.), machinery manufacturing industry chain (CNC machine tools, construction machinery, electrical machinery, 3C automation, industrial robots, lasers, industrial control, drones), food, beverages and pharmaceuticals, medical equipment, agriculture, etc.

Contact Us:

If you have any queries regarding this report or if you would like further information, please contact us:

QY Research Inc.

Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States

EN: https://www.qyresearch.com

E-mail: global@qyresearch.com

Tel: 001-626-842-1666(US) 0086-133 1872 9947(CN) 

JP: https://www.qyresearch.co.jp